For example, the intraperitoneal administration of NMN restores NAD+ biosynthesis and improves glucose intolerance, insulin resistance, and dyslipidemia in age- or HFD-induced diabetic mice by activating SIRT1-catalyzed reactions [42]. The gene discussed is SIRT1; the disease is metabolic syndrome.